Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Leukemia 32Burkitt Lymphoma 25Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17Leukemia, Biphenotypic, Acute 11Lymphoma 10Multiple Myeloma 9Recurrence 8Leukemia, Myeloid, Acute 8Lymphoma, B-Cell, Marginal Zone 7Hodgkin Disease 7Hematologic Neoplasms 7Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Leukemia, Lymphocytic, Chronic, B-Cell 6Blast Crisis 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Waldenstrom Macroglobulinemia 4Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Plasma Cell 4Leukemia, Hairy Cell 4Myelodysplastic Syndromes 3Lymphoma, T-Cell 3Lymphoma, Large-Cell, Anaplastic 3

Interventions

Alemtuzumab 3Cyclophosphamide 2tocilizumab 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methotrexate 1Melphalan 1Etoposide 1Dexamethasone 1Cytarabine 1Calcium Dobesilate 1Busulfan 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphohistiocytosis, Hemophagocytic × Calcium Dobesilate × Other hematologic neoplasm × Clear all
NCT02385110 2024-01-17

Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis

M.D. Anderson Cancer Center

Phase 2 Completed
18 enrolled 10 charts
MyeloidOther hematologic neoplasm

Leukemia, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡